Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada


Food and Drug Regulations

Version of section C.01.010 from 2021-03-31 to 2024-05-01:

 If it is necessary to provide adequate directions for the safe use of a parenteral drug or prescription drug that is used in the treatment or prevention of any disease, disorder or abnormal physical state mentioned in Schedule A.1 to the Act, the disease, disorder or abnormal physical state may be mentioned on the drug’s labels, including any package insert and any document that is provided on request and that sets out supplementary information on the use of the drug, and, in that respect, the drug is exempt from subsections 3(1) and (2) of the Act.

  • SOR/2013-122, s. 6
  • SOR/2014-158, s. 6
  • SOR/2017-18, s. 21(F)
  • SOR/2018-69, s. 14(F)
  • SOR/2021-46, s. 10

Date modified: